# Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity?

> **NCT00578760** · NA · UNKNOWN · sponsor: **University Health Network, Toronto** · enrollment: 110 (estimated)

## Conditions studied

- Hearing Loss
- Ototoxicity

## Interventions

- **DRUG:** aspirin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00578760
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-02
- **Primary completion:** —
- **Final completion:** 2010-02
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2007-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00578760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00578760, "Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity?". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00578760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*